Peter Reilich

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.

Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.

Journal: Annals of neurology

Published: April 22, 2026

Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in Germany.

Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in Germany.

Journal: Neurological research and practice

Published: December 09, 2025

Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Journal: Journal of neurology

Published: March 08, 2025

Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunction.

Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunction.

Journal: Neurological research and practice

Published: January 21, 2025

Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.

Journal: Annals of neurology

Published: December 16, 2024

Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis-a single-center case series and pooled individual patient data meta-analysis.

Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis-a single-center case series and pooled individual patient data meta-analysis.

Journal: Journal of neurology

Published: June 09, 2024

Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Journal: Journal of neurology

Published: May 29, 2024

Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease.

Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease.

Journal: Journal of neurology

Published: May 01, 2024

Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study.

Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study.

Journal: Neurological research and practice

Published: April 25, 2024

Multidimensional care for people with ALS and their families

Multidimensional care for people with ALS and their families

Journal: Fortschritte der Neurologie-Psychiatrie

Published: March 15, 2024

Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.

Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.

Journal: EClinicalMedicine

Published: November 06, 2023

Myelitis as a side effect of tofersen therapy in SOD1-associated ALS.

Myelitis as a side effect of tofersen therapy in SOD1-associated ALS.

Journal: Journal of neurology

Published: September 25, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026